LYSOGUARD® Acnegel

LYSOGUARD® Acnegel- Advanced Dermocosmetic Solution for Acne-Prone Skin

B2B solution for formulators, dermocosmetic brands, private label partners and finished product manufacturers.

egg-derived proteins / alcohol-free / fragrance-free / no silicones / no parabens / no microplastics

Product Overview

LYSOGUARD® Acnegel is a refined dermocosmetic gel platform developed for modern anti-blemish skincare projects targeting oily, impure, combination and acne-prone skin. Its clear gel texture combines lysozyme and ovotransferrin from egg white in a formulation designed to support premium positioning, technical credibility and a more nature-derived approach to skin balance.

Created for business customers rather than retail sale, LYSOGUARD® Acnegel is suited to companies seeking differentiated anti-blemish concepts with a stronger scientific identity and a cleaner formulation story. LYSOGUARD® Acnege is a topical cosmetic gel with a transparent appearance, a 2-year stability profile and an INCI composed of aqua, glycerol, propylene glycol, disteareth-100 IPDI, lysozyme, ovotransferrin and sodium benzoate.

A Distinctive Active Concept

At the core of LYSOGUARD® Acnegel is the combination of two functional proteins derived from egg white: lysozyme and ovotransferrin. Lysozyme is a highly studied antibacterial protein with anti-inflammatory, antiviral and antioxidant activities, while ovotransferrin is characterized by iron-chelating, antibacterial, antifungal and scavenging properties.

This dual-protein concept creates a sophisticated platform for brands looking to move beyond conventional acne-care narratives. It supports a more premium formulation story centered on skin purification, visible comfort and microbiota-conscious care.

Positioning Benefits

  • Premium active story based on egg-derived functional proteins.
  • Clear transparent gel format suitable for modern dermocosmetic positioning.
  • Alcohol-free concept with no need for ethanol or other alcohols on the skin.
  • Fragrance-free profile with no silicones, parabens or microplastics.
  • Suitable for oily, combination, acne-prone and sensitive skin concepts.
  • Strong fit for pharmacy, dermocosmetic and private label development programs.

Performance Profile

LYSOGUARD® Acnegel is supported by in-vitro and in-vivo evaluation, offering a stronger technical foundation for product development. In-vitro testing was conducted on microorganisms associated with acne vulgaris microbiota, including Cutibacterium acnes, Corynebacterium minutissimum, Corynebacterium diphtheriae and Staphylococcus aureus, while in-vivo efficacy was evaluated on 20 volunteers over 28 days.

For brands and R&D teams, this supports a balanced positioning that combines scientific substance with cosmetic elegance. The platform is particularly relevant for anti-blemish and rebalancing lines seeking a gentler yet technically differentiated identity.

Development Opportunities

LYSOGUARD® Acnegel is suitable for a wide range of dermocosmetic applications, from anti-blemish gels to daily balancing care for acne-prone skin. It offers a ready-to-position base for premium skincare ranges requiring both formulation clarity and strong commercial storytelling.

Anti-blemish gel concepts

  • Daily balancing care
  • Soothing products for visibly stressed skin
  • Private label skincare programs
  • Pharmacy-oriented dermocosmetic lines
  • Professional skincare portfolios

Innovation Status

LYSOGUARD® Acnegel combines clean formulation attributes with an innovation-led positioning. The product is described as patent pending, with application numbers 2024398908 and EP4470525, adding further value for partners seeking distinctiveness in competitive anti-blemish categories.

⚠ WARNING: Contains egg-derived ingredients.

B2B Contact

LYSOGUARD® Acnegel is available for professional evaluation only. Technical documentation, samples and development discussions are reserved for formulators, sourcing teams, brand owners and manufacturing partners.[file:1]

For B2B use only. Claims, product positioning and market use must always be evaluated according to local legislation and target market requirements.[file:1]


Show in grid
On

More information

Address
Important notice

Terms of Service

This document informs Users about the technologies that help www.bioseutica.com to achieve the purposes described below. Such technologies allow the Owner to access and store information (for example, by using a Cookie) or resources (for example, by running a script) on a User’s device as they interact with www.bioseutica.com.

Read More

SamplePrivacy